ICON receives FDA warning letter

Download PDF Copy

Editorial Checklist

Reviewed

ICON plcDec 4 2009

ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), today announced it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding clinical study management services provided by the company to one of its clients in relation to two studies conducted between 2004 and 2006. These studies related to the development of an antibiotic for the treatment of complicated skin and skin-structure infections. The FDA letter arises from its inspections of the company’s client and selected clinical sites and follows a similar letter issued to that client.

ICON is committed to working cooperatively and expeditiously with the FDA to address the matters raised in the letter.

Source:

Posted in: Medical Research News

Tags: Antibiotic, Biotechnology, Food, Skin

Comments (0)

Download PDF Copy

Suggested Reading

Topical immunotherapy clears precancerous skin lesions and reduces cancer risk

Topical immunotherapy clears precancerous skin lesions and reduces cancer risk

Ultra-processed foods dominate children's diets from toddlerhood to middle childhood

Ultra-processed foods dominate children's diets from toddlerhood to middle childhood

Six common flying with food allergies myths

Six common flying with food allergies myths

Better food, better mood: The role of diet quality in mental health

Better food, better mood: The role of diet quality in mental health

Ultra-processed foods increase active psoriasis risk, study shows

Ultra-processed foods increase active psoriasis risk, study shows

Frequent ultra-processed food consumption raises mortality risks, especially in women

Frequent ultra-processed food consumption raises mortality risks, especially in women

Updated Food Compass 2.0 improves food health ratings using new diet data

Updated Food Compass 2.0 improves food health ratings using new diet data

Skin as an immune hero: Fighting infections with self-made antibodies

Skin as an immune hero: Fighting infections with self-made antibodies

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Social media normalizes unhealthy food choices, shaping youth habits and brand loyalty